News

Long Island experts weigh in after Novo Nordisk ends deal with Hims & Hers over weight loss meds
Novo Nordisk had been providing Hims & Hers with the FDA-approved Wegovy, an injectable semaglutide used for weight loss ...
Hims & Hers: Panic Sell Or Opportunistic Buy?
The breakup between Hims & Hers and Novo Nordisk has hit HIMS stock hard with a 35% crash. Click here for a full investment ...
Novo exits Hims & Hers partnership, citing ‘deceptive marketing’ concerns
Novo Nordisk A/S scrapped a partnership with Hims & Hers Health Inc. after less than two months, saying the US company is ...
After Its Biggest Drop Ever...Is HIMS A Buy?
Hims & Hers Health HIMS. After $NVO Novo Nordisk abruptly terminated their partnership, citing "deceptive marketing," Hims & Hers fired back with confidence… saying they'll cont ...
Money Morning1d
Hims Stock in Freefall: Read This Before Buying
First, the stock has sliced through two support levels. Shares broke through their 50-day moving average on Monday for the ...
Zacks Investment Research on MSN3h
Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know
Hims & Hers Health, Inc. (HIMS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea ...
HIMS Crashes On Novo GLP-1 Fallout: Buy The Dip Or Bail?
Telehealth company Hims & Hers (HIMS) saw a 34% stock drop after Novo Nordisk (NVO) ended their relationship. Investors must ...
Forbes1d
HIMS Stock To $25?
Hims & Hers Health (NASDAQ: HIMS) experienced a devastating 35% stock crash on June 23, 2025, after Novo Nordisk abruptly terminated their brief partnership. The dramatic sell-off reflects not ...